Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 33, 2018 - Issue 1
Related Research Data
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells
Source:
HAL CCSD
Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse Models.
Source:
Ivyspring International Publisher
Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates with Antitumor Responses
Source:
American Association for Cancer Research (AACR)
Eosinophil Granulocytes Account for Indoleamine 2,3-Dioxygenase-Mediated Immune Escape in Human Non Small Cell Lung Cancer
Source:
Neoplasia Press, Inc. Published by Elsevier Inc.
Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo.
Source:
Frontiers Media SA
Pharmacophore modeling and applications in drug discovery: challenges and recent advances
Source:
Elsevier BV
Abstract 491: NLG919, a novel indoleamine-2,3-dioxygenase (IDO)-pathway inhibitor drug candidate for cancer therapy.
Source:
American Association for Cancer Research
Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival
Source:
Informa UK Limited
1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity.
Source:
HAL CCSD
TRAMP Prostate Cancer Model
Source:
Wiley
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
Source:
Springer Science and Business Media LLC
Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer
Source:
Springer Nature
Regulatory T cells, tumour immunity and immunotherapy
Source:
Springer Science and Business Media LLC
The Combined Effects of Tryptophan Starvation and Tryptophan Catabolites Down-Regulate T Cell Receptor ζ-Chain and Induce a Regulatory Phenotype in Naive T Cells
Source:
The American Association of Immunologists
Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Source:
Royal Society of Chemistry (RSC)
Linking provided by
